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Abstract. Chronic superficial keratitis is a progressive, inflammatory and a potentially blinding disease  
of the canine cornea characterized by an abnormal proliferation of blood vessels, scar tissue, pigment, 
into cornea. It is also known as German Sheperd Pannus, Uberreiterʼs Syndrome, degenerative pannus, 
chronic immune-mediated keratoconjunctivitis syndrome. Despite intensive research efforts, no 
permanent cure exists.  This disease can often be stabilized or controlled with the appropriate therapy. 
The goal was to controll this disorders by appropiate topical combined anti-infective corticosteroid 
ophthalmic suspension with subconjunctival retard depot trimcinolome acetonide injection. 
 




Pannus or chronic superficial keratitis is a bilateral disease  seen most often in German 
Shepherds but which can occur in other breeds as well, is a slowly progressive non-painful 
inflammatory disease of the dog’s cornea(Bedford et al,1979, Dice, 1980). Untreated, pannus 
can eventually lead to blindness. The cause is not known but is believed to be an immune-
mediated disease that increases in severity with exposure to elevated levels of ultraviolet 
sunlight (Denk Nora et al, 2011). The clinical signs are characteristic for the disease.  
As the disease progresses, pigment forming cells migrate from the outer edges into the 
afflicted area, which expands toward the center of the cornea, a gray-pink to a brown and black 
appearance. Vascular granules and connective tissue establish at the border between the sclera 
and the cornea, which is often variously pigmented, and grow into the outside layers of the 
cornea(Williams,1999). This change usually begins in the temporal (outer) or ventral (lower) 
quadrant of the cornea, and severe cases can involve most or all of the corneal surface area 
resulting in blindness. With chronicity the affected areas become black with pigmentation.  
Without treatment, the inflammation will progress to cover the entire cornea and can 
lead to total blindness (Labelle et al, 2013). Chronic superficial keratitis (CSK) is treatable 
however not curable. Lifelong therapy is necessary to keep the disease under control. 
Initially you may to treat aggressively with several medications (corticosteroids, 
cyclosporine, pimecrolimus) up to 6 times a day(Nell Barbara et al.2005). Frequent re-
examinations will be necessary to monitor the progress of the disease. If the disease is 
severe, initial injections may be necessary to stop the disease process. 
 
MATERIALS AND METHODS 
 
Clinical case description and treatment. German Shepherd, male, 3 years old, was 
presented for diagnosis and treatment with generalized bilateral corneal pigmentation, cornea 
being rough with the tendency of desiccation, epithelium appeared to be keratinized, 
accompanied by a marked decrease in visual acuity (Fig.1.). The debut of disease was 3 
months ago, and during that time were tried many types of topical ophthalmic drugs without an 




The animal was examined and by ophthalmologic examination the chronic superficial 
keratitis was diagnosed. Because the dog followed for 3 months an inconsequent and 




Fig.1 Corneal appearance before treatment 
 




 Step 1 
1  week 
Step 2 
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1 every 3 months 
Corticosporin - topical 6 X /day 4 X / day 2 X / day 1 X / day 
 
 
Initial therapy consisted in topical anti-infective and corticosteroid ophthalmic suspension 
(Corticosporin), every 4 hours for one week and after 4 times daily up to one month. Cortisporin 
Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone ophthalmic 
suspension) is a sterile antimicrobial and anti-inflammatory suspension for ophthalmic use.  
Each mL contains: neomycin sulfate equivalent to 3.5 mg neomycin base, polymyxin B 
sulfate equivalent to 10,000 polymyxin B units, and hydrocortisone 10 mg (1%). After one month 
subconjunctival injection with triamcinolome acetonide depot(RTS) was performed every month 
for six months combined with  2 times daily Corticosporin, and now subconjunctival injection 
every 3 months combined with Corticosporin daily. For the subconjunctival injection of RTS a 
very fine needle(22G) was inserted beneath the bulbur conjunctiva at the 10 to 11-oʼclock 
alternate to the 1 to 2-oʼclock position(Fig.2).One time the subconjunctival injection was 
performed at the 6 to 7-oʼclock position. At the site of subconjunctival injection was 
administrated 0,1ml of RTS, and a small bleb appeared at the site of injection beneath 
conjunctiva(Fig.3). The firsts 3  administration were performed under sedation of the animal with 
Domitor, and the next injections were performed after animal restrain in lateral recumbency 




      
       
 Fig.2 Subconjunctival injection                   Fig.3 Subconjunctival bleb appears 
  
Corticosporin was applied by the owner respecting the protocol, one drop in each 
conjunctival inferior sac. 
 
RESULTS AND DISCUSSIONS     
 
Applied treatement provided an execellent controll of clinical signs with  decreasing of 




Fig.4 Clinical appearance improvment under the treatment 
 
The obvious improvement and clinical appearance of transparency of the cornea debut 
after one month of treatemnt. Because of very rigouros need to follow the protocol by the 
owner we  decided to combine the treatement with subconjunctival injection with 
triamcinolome acetonide depot(RTS) to reduce the daily frequency applying of drops and 
compensate by the long term action of the RTS. After one month cornea become more and 
more clear, transparent with an marked decreasing of pigment inside of superficial corneal 
stroma (Fig.4.). At the half ventral part of cornea are persisted an remanant pigmentation.  
This remanant pigmantation are problably due to a lower difusion in the ventral half  of 
the RTS subconjunctival injection administrated all the time(except one time) in the dorsal half.  
This demonstrate the efficiency of subconjuctival injection with triamcinolome acetonide 




disease..The alternate administration in dorsal and ventral half under the bulbar conjunctiva for 
controlling the corneal pigmentation require further investigation. Topical treatment apply 
combined with subconjunctival injection ensued preservation the vision of dogs and the 
transparency of the cornea, with a reducing frequency of daily topical drop  at minimum. 
Chronic superficial keratitis can be controlled by  a variety of medical, surgical, 
methods  or by iradition, but cannot be totally cured. Owners must be counselled of the need 
for life long therapy to control the disease. Initial therapy consist of topical corticosteroid 
ointments or solution 3-4 times daily for 3 to 4 weeks, following by a reduced maintenace 
protocol. Dogs on long term steroids must be monitored for ocular additional infection or 
corneal ulceration.Topical cyclosporine or pimecrolimus with or without cortocosteroids has 
been shown ameliorating the corneal simptoms(Williams et al., 1995, Nell Barbara et al.,2005). 
In many cases subconjunctival injection are needed in addition to  topical therapy for 
controlof the disease. If topical and subconjunctival corticosteroids are ineffective, application 
of beta-radiation may be used. Superficial keratectomy may be performed for severe cases 




This clinical case of  chronic superficial keratitis  in German Shepherd presented and 
proved  the  successful of topical combination treatment of  topical antibiotic-corticosteroid 
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